Ryman Healthcare Limited (RYHTY)
OTCMKTS
· Delayed Price · Currency is USD
7.35
0.00 (0.00%)
Jun 11, 2025, 8:00 PM EDT
Ryman Healthcare Cash Flow Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | -436.83 | -169.67 | 257.84 | 692.87 | 423.06 | Upgrade
|
Depreciation & Amortization | 38.87 | 35.37 | 25.97 | 30.59 | 27.23 | Upgrade
|
Other Amortization | 9.59 | 10.62 | 11.74 | 5.11 | 5.14 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | - | - | 15.1 | Upgrade
|
Asset Writedown & Restructuring Costs | 3.77 | 135.63 | -420.47 | -745.89 | -416.85 | Upgrade
|
Stock-Based Compensation | 2.43 | 2.93 | - | - | - | Upgrade
|
Other Operating Activities | 213 | -116.75 | 103.22 | 33.28 | -31.62 | Upgrade
|
Change in Accounts Receivable | -3.92 | -21.98 | -46.55 | -129.02 | -92.57 | Upgrade
|
Change in Inventory | 2.37 | 2.94 | 11.63 | 0.39 | -26.74 | Upgrade
|
Change in Accounts Payable | 6.35 | -2.03 | 41.11 | 9.17 | 4.85 | Upgrade
|
Change in Unearned Revenue | 43.16 | 41.59 | 18.02 | 9.44 | 7.52 | Upgrade
|
Change in Other Net Operating Assets | 531.47 | 676.61 | 639.43 | 680.03 | 498 | Upgrade
|
Operating Cash Flow | 410.25 | 595.26 | 641.95 | 585.98 | 413.12 | Upgrade
|
Operating Cash Flow Growth | -31.08% | -7.27% | 9.55% | 41.84% | -8.15% | Upgrade
|
Capital Expenditures | -155.59 | -258.82 | -422.94 | -334.29 | -256.6 | Upgrade
|
Sale of Property, Plant & Equipment | 7.13 | 15.28 | 19.65 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -3.11 | -6.72 | -20.11 | -14.35 | -9.46 | Upgrade
|
Other Investing Activities | 2.58 | 5.12 | 1.2 | -4.28 | -0.92 | Upgrade
|
Investing Cash Flow | -525.58 | -778.83 | -1,031 | -787.31 | -844.48 | Upgrade
|
Long-Term Debt Issued | - | 201.22 | 436.72 | 326.92 | 566.87 | Upgrade
|
Short-Term Debt Repaid | -275.09 | - | - | - | - | Upgrade
|
Long-Term Debt Repaid | -610.25 | -3.37 | -752.12 | -2.66 | -39.19 | Upgrade
|
Total Debt Repaid | -885.34 | -3.37 | -752.12 | -2.66 | -39.19 | Upgrade
|
Net Debt Issued (Repaid) | -885.34 | 197.85 | -315.4 | 324.26 | 527.69 | Upgrade
|
Issuance of Common Stock | 6.36 | - | 2.64 | - | - | Upgrade
|
Repurchase of Common Stock | - | - | - | -2.79 | -3.03 | Upgrade
|
Common Dividends Paid | - | - | -68.09 | -112 | -107.5 | Upgrade
|
Other Financing Activities | 970.16 | -0.35 | 769.44 | - | - | Upgrade
|
Financing Cash Flow | 91.18 | 197.5 | 388.6 | 209.47 | 417.16 | Upgrade
|
Net Cash Flow | -24.15 | 13.93 | -0.43 | 8.14 | -14.2 | Upgrade
|
Free Cash Flow | 254.66 | 336.44 | 219.01 | 251.68 | 156.52 | Upgrade
|
Free Cash Flow Growth | -24.31% | 53.62% | -12.98% | 60.80% | 4.56% | Upgrade
|
Free Cash Flow Margin | 33.55% | 48.93% | 37.66% | 49.47% | 34.35% | Upgrade
|
Free Cash Flow Per Share | 0.36 | 0.49 | 0.42 | 0.50 | 0.31 | Upgrade
|
Cash Interest Paid | 127.1 | 36.79 | 46.86 | 29.24 | 18.57 | Upgrade
|
Levered Free Cash Flow | 300.39 | 254.52 | 3,883 | -120.36 | -349.06 | Upgrade
|
Unlevered Free Cash Flow | 408.36 | 304.18 | 3,881 | -101.2 | -336.96 | Upgrade
|
Change in Net Working Capital | -541.76 | -564.77 | -4,285 | -207.48 | 120.78 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.